Bayer Blamed For 22,000 Trasylol-Related Deaths

German-based Bayer Pharmaceuticals, maker of Trasylol – a drug used to limit bleeding in heart surgery – has been blamed for 22,000 deaths that have been linked to the drug. Industry and legal experts say that Bayer knew about the problems linked to Trasylol years ago, but chose not to act.

Bayer: Science for a Better Life?

Bayer’s trademark slogan, “Bayer: Science for a Better Life”, may not match its reputation – especially since CBS’s 60 Minutes interviewed Dr. Dennis Mangano. Mangano published a study in January 2006 that found Trasylol use doubled patients’ risk of kidney failure, heart failure and had a 181 percent increase in the risk of stroke. Mangano and other industry experts claim that Bayer knew about these issues many years ago, but refused to take the drug off the market – a decision that may have caused 22,000 patients to die in vain.

Bayer seeks consumer confidence

Bayer’s website,, seeks consumer confidence, but is that just talk? According to the site:

We seek to retain society’s confidence through performance, flexibility and open communication as we work in pursuit of our overriding goals: to steadily create corporate value and generate high value-added for the benefit of our stockholders, our employees and the community in every country in which we operate.

Unfortunately, open communication isn’t what the company seems to have delivered. Nobody knows that better than the family of Joe Rangone, a 53 year old victim of Trasylol use. In a recent 60 Minute’s segment, correspondent Scott Pelley interviewed Rangone’s family. Rangone’s wife and daughter told Pelley that he had been admitted to the hospital in 2005 for heart surgery and that his operative risk was only five percent. However, doctors used Trasylol during his surgery and Rangone suffered two heart attacks, renal (kidney) failure and died in 2006 as a result. His family has brought a lawsuit against Bayer.

FDA would have acted sooner

Dr. William Hiatt, Chairman of the Food and Drug Administration’s (FDA’s) advisory panel, told CBS’s Pelley that he would have voted to remove Trasylol from the market had he known about Bayer’s study. It wasn’t until a Canadian study of the drug was halted because too many of the participants were dying that the FDA reacted and pulled the drug off shelves.

If you or a loved one may have been injured or died due to the use of Trasylol, contact an attorney whose practice focuses in this area of law to discuss your situation. The consultation is free and without obligation. To contact a qualified attorney, please click here.

Back To Library Index